Fundraising FoxQV Bioelectronics
7 known investors
Find your way into QV Bioelectronics
Sign up to see every warm intro you have to QV Bioelectronics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the QV Bioelectronics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
QV Bioelectronics develops GRACE, an implantable electric field delivery platform designed to treat aggressive cancers by delivering continuous therapeutic electric fields directly to tumor sites. The company targets oncology indications including glioblastoma, brain metastases, and pancreatic cancer.
Founders & leadership
Investors · 7
How we know: Elbow Beach Capital's portfolio page · qvbio.co.uk · Not right? Tell us
How we know: Northern Gritstone's portfolio page · qvbio.co.uk · the VCSheet dataset · Not right? Tell us
How we know: qvbio.co.uk · open dataset · 5k.vc investor directory · sosv.com · Not right? Tell us
How we know: qvbio.co.uk · Not right? Tell us
How we know: open dataset · 5k.vc investor directory · Not right? Tell us
How we know: qvbio.co.uk · Not right? Tell us
Also in the syndicate · 1
Funding
SEC filings, press & company announcements- Undisclosed amountPre-Series AJan 2023 · 2 sources
Fink Family Office (lead), Science Angel Syndicate (lead), Catapult Ventures, Elbow Beach Capital, Northern Gritstone, SOSV
Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
Companies House · registry record
View on Companies House ↗- Registered name
- QV BIOELECTRONICS LTD.
- Company number
- 11608210
- Status
- Active
- Company type
- Private limited company
- Incorporated
- 7 Oct 2018
- Registered office
- 21lga Alderley Park, Nether Alderley, Cheshire, SK10 4TG
- Nature of business (SIC)
- 26600 — Manufacture of irradiation, electromedical and electrotherapeutic equipment72110 — Research and experimental development on biotechnology
- Previous names
- HONEYCOMB BIOTECHNOLOGY LIMITED (2018–2019)
- Accounts
- last made up to 31 Dec 2024 · next due 31 Dec 2026
- Confirmation statement
- last made up to 23 Mar 2026 · next due 6 Apr 2027
Current officers · 5
- Christopher John Bullock — director, appointed 7 Oct 2018
- Carl Jason Daintree — director, appointed 22 May 2026
- Alexander Michael Fink — director, appointed 10 Dec 2025
- Richard Zhiming Fu — director, appointed 7 Oct 2018
- Mark Horncastle — director, appointed 10 Dec 2025
Source: Companies House public register · retrieved 4 Oct 2026. Contains public sector information licensed under the Open Government Licence v3.0.
In the news
Frequently asked questions
- What does QV Bioelectronics do?
- QV Bioelectronics develops GRACE, an implantable electric field delivery platform designed to treat aggressive cancers by delivering continuous therapeutic electric fields directly to tumor sites. The company targets oncology indications including glioblastoma, brain metastases, and pancreatic cancer.
- Who founded QV Bioelectronics?
- QV Bioelectronics was founded by Dr Chris Bullock, Dr Richard Fu.
- Who are QV Bioelectronics's investors?
- QV Bioelectronics's investors include Elbow Beach Capital, Northern Gritstone, SOSV, Catapult Ventures, Empirical Ventures, Science Angel Syndicate.